![Triplet Therapy Offers New Treatment Option for Patients with Relapsed or Refractory Multiple Myeloma – ASCO](https://oncodaily.com/pub/uploads/2024/02/download-10-1280x1280.jpg)
Photo taken from American Society of Clinical Oncology (ASCO)/LinkedIn
Feb 6, 2024, 16:42
Triplet Therapy Offers New Treatment Option for Patients with Relapsed or Refractory Multiple Myeloma – ASCO
American Society of Clinical Oncology (ASCO) shared a post on their LinkedIn page:
“Latest from ASCO Plenary Series: Triplet Therapy Offers New Treatment Option for Patients with Relapsed or Refractory Multiple Myeloma. Tune in tomorrow, February 6, at 3 PM ET for the live presentation, expert discussion, and Q&A.
View abstract.”
Source: American Society of Clinical Oncology (ASCO)/LinkedIn
Jul 26, 2024, 00:27